8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine

C90H89BBrCl3F6N24O8 — CID 158280318

IUPAC8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine
SMILESC1=CN=C(C2CNCCO2)C1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1B1OC(C)(C)C(C)(C)O1.Clc1cc(Br)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1
InChIInChI=1S/C28H24F3N7O2.C20H22BF3N2O3.2C14H14ClN5O.C8H12N2O.C6H3BrClN3/c1-17-21(13-20(15-34-17)35-27(39)18-4-2-5-19(12-18)28(29,30)31)23-14-24(26-33-8-9-38(26)36-23)37-10-11-40-25(16-37)22-6-3-7-32-22;1-12-16(21-28-18(2,3)19(4,5)29-21)10-15(11-25-12)26-17(27)13-7-6-8-14(9-13)20(22,23)24;2*15-13-8-11(14-17-4-5-20(14)18-13)19-6-7-21-12(9-19)10-2-1-3-16-10;1-2-7(10-3-1)8-6-9-4-5-11-8;7-4-3-5(8)10-11-2-1-9-6(4)11/h2-5,7-9,12-15,25H,6,10-11,16H2,1H3,(H,35,39);6-11H,1-5H3,(H,26,27);2*1,3-5,8,12H,2,6-7,9H2;1,3,8-9H,2,4-6H2;1-3H
InChIKeyGKDBKWNZXYFCSV-UHFFFAOYSA-N
MW1945.92 g/mol
LogP15.27
Rot. Bonds13

About 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine

8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine (PubChem CID 158280318) has the molecular formula C90H89BBrCl3F6N24O8 and a molecular weight of 1945.92 g/mol. Its IUPAC name is 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine.

Molecular Properties

Compound Name8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine
PubChem CID158280318
Molecular FormulaC90H89BBrCl3F6N24O8
Molecular Weight1945.92 g/mol
Exact Mass1942.55
IUPAC Name8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine
SMILESC1=CN=C(C2CNCCO2)C1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1B1OC(C)(C)C(C)(C)O1.Clc1cc(Br)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1
InChIInChI=1S/C28H24F3N7O2.C20H22BF3N2O3.2C14H14ClN5O.C8H12N2O.C6H3BrClN3/c1-17-21(13-20(15-34-17)35-27(39)18-4-2-5-19(12-18)28(29,30)31)23-14-24(26-33-8-9-38(26)36-23)37-10-11-40-25(16-37)22-6-3-7-32-22;1-12-16(21-28-18(2,3)19(4,5)29-21)10-15(11-25-12)26-17(27)13-7-6-8-14(9-13)20(22,23)24;2*15-13-8-11(14-17-4-5-20(14)18-13)19-6-7-21-12(9-19)10-2-1-3-16-10;1-2-7(10-3-1)8-6-9-4-5-11-8;7-4-3-5(8)10-11-2-1-9-6(4)11/h2-5,7-9,12-15,25H,6,10-11,16H2,1H3,(H,35,39);6-11H,1-5H3,(H,26,27);2*1,3-5,8,12H,2,6-7,9H2;1,3,8-9H,2,4-6H2;1-3H
InChIKeyGKDBKWNZXYFCSV-UHFFFAOYSA-N
XLogP15.27
TPSA331.31 Ų
H-Bond Donors3
H-Bond Acceptors30
Rotatable Bonds13
Heavy Atoms133
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001945.92
LogP ≤ 515.27
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine?
The IUPAC name of 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine (CID 158280318) is 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine.
What is the SMILES notation for 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine?
The canonical SMILES for 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine is C1=CN=C(C2CNCCO2)C1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1B1OC(C)(C)C(C)(C)O1.Clc1cc(Br)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.Clc1cc(N2CCOC(C3=NC=CC3)C2)c2nccn2n1.
What is the InChIKey of 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine?
The InChIKey is GKDBKWNZXYFCSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H24F3N7O2.C20H22BF3N2O3.2C14H14ClN5O.C8H12N2O.C6H3BrClN3/c1-17-21(13-20(15-34-17)35-27(39)18-4-2-5-19(12-18)28(29,30)31)23-14-24(26-33-8-9-38(26)36-23)37-10-11-40-25(16-37)22-6-3-7-32-22;1-12-16(21-28-18(2,3)19(4,5)29-21)10-15(11-25-12)26-17(27)13-7-6-8-14(9-13)20(22,23)24;2*15-13-8-11(14-17-4-5-20(14)18-13)19-6-7-21-12(9-19)10-2-1-3-16-10;1-2-7(10-3-1)8-6-9-4-5-11-8;7-4-3-5(8)10-11-2-1-9-6(4)11/h2-5,7-9,12-15,25H,6,10-11,16H2,1H3,(H,35,39);6-11H,1-5H3,(H,26,27);2*1,3-5,8,12H,2,6-7,9H2;1,3,8-9H,2,4-6H2;1-3H.
What are the key properties of 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine?
8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine has a molecular weight of 1945.92 g/mol, XLogP of 15.27, 13 rotatable bonds, 3 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 8-bromo-6-chloroimidazo[1,2-b]pyridazine;bis(4-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-2-(3H-pyrrol-2-yl)morpholine);N-[6-methyl-5-[8-[2-(3H-pyrrol-2-yl)morpholin-4-yl]imidazo[1,2-b]pyridazin-6-yl]-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide;2-(3H-pyrrol-2-yl)morpholine is sourced from PubChem (CID 158280318), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).